Financial Performance - The company's operating revenue for Q3 2025 reached ¥5,031,850,801.87, representing a year-on-year increase of 6.48%[5] - Net profit attributable to shareholders was ¥92,797,723.25, up 49.14% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥90,104,355.70, reflecting a 43.01% increase year-on-year[5] - Basic and diluted earnings per share both stood at ¥0.26, marking a 49.14% increase from the previous year[5] - Total operating revenue for the current period reached ¥14,860,753,939.01, an increase of 10.2% compared to ¥13,487,182,811.91 in the previous period[20] - Net profit for the current period was ¥284,049,040.09, representing a 43.3% increase from ¥198,181,282.78 in the previous period[22] - The net profit attributable to shareholders of the parent company was ¥229,833,549.09, compared to ¥158,499,162.85, marking a growth of 45.0%[22] - Basic and diluted earnings per share for the current period were both ¥0.64, up from ¥0.44 in the previous period[22] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥14,686,136,571.84, a 12.00% increase from the end of the previous year[5] - Total liabilities increased to ¥12,266,187,059.91 from ¥11,335,476,422.64, reflecting a growth of 8.2%[18] - Shareholders' equity attributable to the parent company reached ¥2,077,221,495.65, up 40.24% from the previous year-end[5] - Total equity attributable to shareholders of the parent company rose to ¥2,077,221,495.65, compared to ¥1,481,229,497.57, an increase of 40.2%[18] - The company has a total of 14.18 billion in current assets, up from 12.60 billion, reflecting a growth of approximately 12.6%[17] - Non-current assets totaled CNY 510.35 million, slightly down from CNY 516.49 million, indicating a decrease of about 1.5%[17] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥50,576,688.13, showing a significant increase of 104.63% compared to the same period last year[5] - Operating cash inflow for the current period reached ¥17,599,539,011.49, an increase of 6.06% from ¥15,650,057,820.67 in the previous period[25] - Net cash flow from operating activities was ¥50,576,688.13, a significant recovery from a negative cash flow of ¥-1,092,588,441.89 in the previous period[25] - Cash inflow from financing activities amounted to ¥4,133,187,948.57, an increase of 6.73% from ¥3,873,360,806.34 in the previous period[27] - The ending balance of cash and cash equivalents increased to ¥1,787,466,702.66, compared to ¥903,432,646.05 in the previous period[27] - Cash received from other financing activities was ¥49,992,256.33, with no previous amount reported[27] Shareholder Information - The company reported a total of 37,987 common shareholders at the end of the reporting period[10] - The largest shareholder, Xiamen Jianfa Medical, holds a 43.37% stake, while the second-largest shareholder, Pingxiang Changheyuan Investment Management, holds 26.80%[12] Initial Public Offering - The company completed its initial public offering during the reporting period, which contributed to the increase in shareholders' equity[9] - The company successfully completed its initial public offering (IPO) of 63,193,277 shares on September 25, 2025, under the stock code "301584" on the Shenzhen Stock Exchange[14] Operational Insights - The increase in net profit is attributed to the growth in the company's SPD management services business[9] - The company has plans for market expansion and new product development as part of its growth strategy moving forward[14] - The company reported a significant increase in tax payable, which rose to ¥86,554,671.54 from ¥52,066,299.53, a growth of 66.2%[18] - The company has ongoing research and development expenses of ¥18,081,750.52, slightly up from ¥17,235,616.66, indicating continued investment in innovation[21] Inventory and Receivables - Accounts receivable increased significantly to CNY 8.05 billion from CNY 6.47 billion, representing a growth of approximately 24.3%[17] - Inventory decreased to CNY 3.29 billion from CNY 3.48 billion, showing a decline of about 4.4%[17] - Short-term borrowings slightly decreased to CNY 3.77 billion from CNY 3.85 billion, a reduction of approximately 2.9%[17] Financial Reporting - Cash outflow from investment activities totaled ¥53,310,612.12, compared to ¥51,417,469.32 in the previous period, resulting in a net cash outflow of ¥53,278,391.12[25] - The company has not audited its third-quarter financial report[28]
建发致新(301584) - 2025 Q3 - 季度财报